| HOME >> BIOLOGY >> TECHNOLOGY |
with GAAP, adjusted for the effects of share-based compensation, and
expense and/or amortization of acquired intangible assets.
-- Non-GAAP operating profit represents operating profit reported in
accordance with GAAP, adjusted for the effects of share-based
compensation, and expense and/or amortization of acquired intangible
assets including, but not limited to, in-progress research and
development (IPR&D).
-- Non-GAAP net income represents net income reported in accordance with
GAAP, adjusted for the effects of share-based compensation, and expense
and/or amortization of acquired intangible assets including, but not
limited to, IPR&D, all net of related tax impact.
-- Non-GAAP earnings per share represents non-GAAP net income divided by
the number of shares used in computing basic and diluted earnings per
share in accordance with GAAP, and excludes the impact of the deemed
dividends for the basic calculation.
In addition to Mindray's consolidated financial results under GAAP, the
Company also provides non-GAAP financial measures, including non-GAAP gross
margin, non-GAAP operating profit, non-GAAP net income and non-GAAP
earnings per share on a basic and fully diluted basis. The Company believes
that both management and investors benefit from referring to these non-GAAP
financial measures in assessing Mindray's financial performance and
liquidity and when planning and forecasting future periods. These non-GAAP
operating measures are useful for understanding and assessing Mindray's
underlying business performance and operating trends and the Company
expects to report operating profit and net income on a non-GAAP basis using
a consistent method on a quarterly basis going forwar
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved |